MovDisordV3, PascalFrancis, Corpus, bibRecord, 003043

Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease

Identifieur interne : 003043 ( PascalFrancis/Corpus ); précédent : 003042; suivant : 003044

Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease

Auteurs : N. Syed ; J. Murphy ; T. Jr Zimmerman ; M. H. Mark ; J. I. Sage

Source :

Movement disorders [ 0885-3185 ] ; 1998.

RBID : Pascal:98-0177456

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Lévodopa, Chimiothérapie, Antiparkinsonien, Long terme, Voie entérale, Dyskinésie, Pompe, Traitement, Voie administration, Indication, Adulte, Fluctuation motrice.

English descriptors

KwdEn :
- Adult, Antiparkinson agent, Chemotherapy, Dyskinesia, Enteral administration, Indication, Levodopa, Long term, Parkinson disease, Pump, Route of administration, Treatment.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 13`
A06				`@2 2`
A08	`01`	`1`	`ENG`	`@1 Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease`
A11	`01`	`1`		`@1 SYED (N.)`
A11	`02`	`1`		`@1 MURPHY (J.)`
A11	`03`	`1`		`@1 ZIMMERMAN (T. JR)`
A11	`04`	`1`		`@1 MARK (M. H.)`
A11	`05`	`1`		`@1 SAGE (J. I.)`
A14	`01`			`@1 Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School @2 New Brunswick, New Jersey @3 USA @Z 1 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut.`
A14	`02`			`@1 Associated Neurologists @2 Danbury, Connecticut @3 USA @Z 2 aut.`
A20				`@1 336-338`
A21				`@1 1998`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000079238580210`
A44				`@0 0000 @1 © 1998 INIST-CNRS. All rights reserved.`
A45				`@0 13 ref.`
A47	`01`	`1`		`@0 98-0177456`
A60				`@1 P @3 CC`
A61				`@0 A`
A64		`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B02B06`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Lévodopa @5 04`
C03	`02`	`X`	`ENG`	`@0 Levodopa @5 04`
C03	`02`	`X`	`SPA`	`@0 Levodopa @5 04`
C03	`03`	`X`	`FRE`	`@0 Chimiothérapie @5 05`
C03	`03`	`X`	`ENG`	`@0 Chemotherapy @5 05`
C03	`03`	`X`	`SPA`	`@0 Quimioterapia @5 05`
C03	`04`	`X`	`FRE`	`@0 Antiparkinsonien @5 06`
C03	`04`	`X`	`ENG`	`@0 Antiparkinson agent @5 06`
C03	`04`	`X`	`SPA`	`@0 Antiparkinsoniano @5 06`
C03	`05`	`X`	`FRE`	`@0 Long terme @5 07`
C03	`05`	`X`	`ENG`	`@0 Long term @5 07`
C03	`05`	`X`	`SPA`	`@0 Largo plazo @5 07`
C03	`06`	`X`	`FRE`	`@0 Voie entérale @5 08`
C03	`06`	`X`	`ENG`	`@0 Enteral administration @5 08`
C03	`06`	`X`	`SPA`	`@0 Vía enteral @5 08`
C03	`07`	`X`	`FRE`	`@0 Dyskinésie @5 10`
C03	`07`	`X`	`ENG`	`@0 Dyskinesia @5 10`
C03	`07`	`X`	`SPA`	`@0 Disquinesia @5 10`
C03	`08`	`X`	`FRE`	`@0 Pompe @5 13`
C03	`08`	`X`	`ENG`	`@0 Pump @5 13`
C03	`08`	`X`	`GER`	`@0 Pumpe @5 13`
C03	`08`	`X`	`SPA`	`@0 Bomba @5 13`
C03	`09`	`X`	`FRE`	`@0 Traitement @5 17`
C03	`09`	`X`	`ENG`	`@0 Treatment @5 17`
C03	`09`	`X`	`GER`	`@0 Aufbereiten @5 17`
C03	`09`	`X`	`SPA`	`@0 Tratamiento @5 17`
C03	`10`	`X`	`FRE`	`@0 Voie administration @5 18`
C03	`10`	`X`	`ENG`	`@0 Route of administration @5 18`
C03	`10`	`X`	`SPA`	`@0 Vía administración @5 18`
C03	`11`	`X`	`FRE`	`@0 Indication @5 19`
C03	`11`	`X`	`ENG`	`@0 Indication @5 19`
C03	`11`	`X`	`SPA`	`@0 Indicación @5 19`
C03	`12`	`X`	`FRE`	`@0 Adulte @5 20`
C03	`12`	`X`	`ENG`	`@0 Adult @5 20`
C03	`12`	`X`	`SPA`	`@0 Adulto @5 20`
C03	`13`	`X`	`FRE`	`@0 Fluctuation motrice @4 INC @5 86`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`03`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`03`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`03`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`04`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`04`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`04`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`05`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`05`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`05`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`06`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`06`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`06`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`07`	`X`	`FRE`	`@0 Trouble neurologique @5 62`
C07	`07`	`X`	`ENG`	`@0 Neurological disorder @5 62`
C07	`07`	`X`	`SPA`	`@0 Trastorno neurológico @5 62`
C07	`08`	`X`	`FRE`	`@0 Mouvement involontaire @5 63`
C07	`08`	`X`	`ENG`	`@0 Involuntary movement @5 63`
C07	`08`	`X`	`SPA`	`@0 Movimiento involuntario @5 63`
N21				`@1 117`

Format Inist (serveur)

NO :	PASCAL 98-0177456 INIST
ET :	Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease
AU :	SYED (N.); MURPHY (J.); ZIMMERMAN (T. JR); MARK (M. H.); SAGE (J. I.)
AF :	Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School/New Brunswick, New Jersey/Etats-Unis (1 aut., 3 aut., 4 aut., 5 aut.); Associated Neurologists/Danbury, Connecticut/Etats-Unis (2 aut.)
DT :	Publication en série; Courte communication, note brève; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1998; Vol. 13; No. 2; Pp. 336-338; Bibl. 13 ref.
LA :	Anglais
CC :	002B02B06
FD :	Parkinson maladie; Lévodopa; Chimiothérapie; Antiparkinsonien; Long terme; Voie entérale; Dyskinésie; Pompe; Traitement; Voie administration; Indication; Adulte; Fluctuation motrice
FG :	Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Trouble neurologique; Mouvement involontaire
ED :	Parkinson disease; Levodopa; Chemotherapy; Antiparkinson agent; Long term; Enteral administration; Dyskinesia; Pump; Treatment; Route of administration; Indication; Adult
EG :	Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Neurological disorder; Involuntary movement
GD :	Pumpe; Aufbereiten
SD :	Parkinson enfermedad; Levodopa; Quimioterapia; Antiparkinsoniano; Largo plazo; Vía enteral; Disquinesia; Bomba; Tratamiento; Vía administración; Indicación; Adulto
LO :	INIST-20953.354000079238580210
ID :	98-0177456

Links to Exploration step

Pascal:98-0177456

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease</title>
<author><name sortKey="Syed, N" sort="Syed, N" uniqKey="Syed N" first="N." last="Syed">N. Syed</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Murphy, J" sort="Murphy, J" uniqKey="Murphy J" first="J." last="Murphy">J. Murphy</name>
<affiliation><inist:fA14 i1="02"><s1>Associated Neurologists</s1>
<s2>Danbury, Connecticut</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zimmerman, T Jr" sort="Zimmerman, T Jr" uniqKey="Zimmerman T" first="T. Jr" last="Zimmerman">T. Jr Zimmerman</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mark, M H" sort="Mark, M H" uniqKey="Mark M" first="M. H." last="Mark">M. H. Mark</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sage, J I" sort="Sage, J I" uniqKey="Sage J" first="J. I." last="Sage">J. I. Sage</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">98-0177456</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 98-0177456 INIST</idno>
<idno type="RBID">Pascal:98-0177456</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003043</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease</title>
<author><name sortKey="Syed, N" sort="Syed, N" uniqKey="Syed N" first="N." last="Syed">N. Syed</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Murphy, J" sort="Murphy, J" uniqKey="Murphy J" first="J." last="Murphy">J. Murphy</name>
<affiliation><inist:fA14 i1="02"><s1>Associated Neurologists</s1>
<s2>Danbury, Connecticut</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zimmerman, T Jr" sort="Zimmerman, T Jr" uniqKey="Zimmerman T" first="T. Jr" last="Zimmerman">T. Jr Zimmerman</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mark, M H" sort="Mark, M H" uniqKey="Mark M" first="M. H." last="Mark">M. H. Mark</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sage, J I" sort="Sage, J I" uniqKey="Sage J" first="J. I." last="Sage">J. I. Sage</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Dyskinesia</term>
<term>Enteral administration</term>
<term>Indication</term>
<term>Levodopa</term>
<term>Long term</term>
<term>Parkinson disease</term>
<term>Pump</term>
<term>Route of administration</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Lévodopa</term>
<term>Chimiothérapie</term>
<term>Antiparkinsonien</term>
<term>Long terme</term>
<term>Voie entérale</term>
<term>Dyskinésie</term>
<term>Pompe</term>
<term>Traitement</term>
<term>Voie administration</term>
<term>Indication</term>
<term>Adulte</term>
<term>Fluctuation motrice</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>13</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SYED (N.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>MURPHY (J.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>ZIMMERMAN (T. JR)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>MARK (M. H.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>SAGE (J. I.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Associated Neurologists</s1>
<s2>Danbury, Connecticut</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>336-338</s1>
</fA20>
<fA21><s1>1998</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000079238580210</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1998 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>13 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>98-0177456</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Lévodopa</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Levodopa</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Levodopa</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Long terme</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Long term</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Largo plazo</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Voie entérale</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Enteral administration</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Vía enteral</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Dyskinésie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Dyskinesia</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Disquinesia</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Pompe</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Pump</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="GER"><s0>Pumpe</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Bomba</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Voie administration</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Route of administration</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Vía administración</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Indication</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Indication</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Indicación</s0>
<s5>19</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Adulte</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Adult</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Adulto</s0>
<s5>20</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Fluctuation motrice</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>62</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>62</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>62</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>63</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>63</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>63</s5>
</fC07>
<fN21><s1>117</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 98-0177456 INIST</NO>
<ET>Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease</ET>
<AU>SYED (N.); MURPHY (J.); ZIMMERMAN (T. JR); MARK (M. H.); SAGE (J. I.)</AU>
<AF>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School/New Brunswick, New Jersey/Etats-Unis (1 aut., 3 aut., 4 aut., 5 aut.); Associated Neurologists/Danbury, Connecticut/Etats-Unis (2 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1998; Vol. 13; No. 2; Pp. 336-338; Bibl. 13 ref.</SO>
<LA>Anglais</LA>
<CC>002B02B06</CC>
<FD>Parkinson maladie; Lévodopa; Chimiothérapie; Antiparkinsonien; Long terme; Voie entérale; Dyskinésie; Pompe; Traitement; Voie administration; Indication; Adulte; Fluctuation motrice</FD>
<FG>Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Trouble neurologique; Mouvement involontaire</FG>
<ED>Parkinson disease; Levodopa; Chemotherapy; Antiparkinson agent; Long term; Enteral administration; Dyskinesia; Pump; Treatment; Route of administration; Indication; Adult</ED>
<EG>Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Neurological disorder; Involuntary movement</EG>
<GD>Pumpe; Aufbereiten</GD>
<SD>Parkinson enfermedad; Levodopa; Quimioterapia; Antiparkinsoniano; Largo plazo; Vía enteral; Disquinesia; Bomba; Tratamiento; Vía administración; Indicación; Adulto</SD>
<LO>INIST-20953.354000079238580210</LO>
<ID>98-0177456</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003043 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003043 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:98-0177456
   |texte=   Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease

Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease

Source :

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri